MOVAPO
MOVAPO
Discontinued
DIN Number
02459132
Drug Class
Human
Market Date
Sep 7, 2017
Company
HC
paladin pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02459132
AIG Number0158570001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BC07 APOMORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification28:36.20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
APOMORPHINE HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: APOMORPHINE HYDROCHLORIDE